NCT04667416 - Safety and Preliminary Efficacy of PalinGen Flow Amniotic Tissue Allograft in Chronic Ulcers of the Lower Extremities | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 19, 2021

Primary Completion Date

March 31, 2024

Study Completion Date

January 31, 2025

Conditions

Chronic Ulcer of Lower Extremity

Interventions

BIOLOGICAL

PalinGen Flow Amniotic Tissue Allograft

Participants will receive wound size-dependent dose of PalinGen Flow liquid human amniotic tissue allograft by subcutaneous injection in addition to SOC.

Trial Locations (7)

76104

Acclaim Bone & Joint Institute and Plastic Surgery, Fort Worth

78501

Futuro Clinical Trials, McAllen

92083

ILD Research Center, Vista

93710

Limb Preservation Platform, Fresno

94115

Center for Clinical Research, San Francisco

94546

Center for Clinical Research, Castro Valley

95608

Center for Clinical Research, Carmichael